Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicentre, Open, Non-comparative, Phase III Study on the Efficacy, Pharmacokinetics, and Safety of Two Subcutaneous Injections of Triptorelin Embonate 22.5 mg 6-month Formulation in Patients With Advanced Prostate Cancer

NCT01656161 is registered in ClinicalTrials.gov with Debiopharm International SA as lead sponsor.

NCT NCT01656161
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01656161 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicentre, Open, Non-comparative, Phase III Study on the Efficacy, Pharmacokinetics, and Safety of Two Subcutaneous Injections of Triptorelin Embonate 22.5 mg 6-month Formulation in Patients With Advanced Prostate Cancer
Lead sponsor
Debiopharm International SA
Phase
Phase 3
Overall status
Completed
Start date
July 31, 2012
Completion date
August 31, 2013
Enrollment
120 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer